Synth Finance Logo Logo API

Aelis Farma S.A.S. (69O) logo

PNG 3.53 KB
Download
https://logo.synthfinance.com/ticker/69O
HTML
<img src="https://logo.synthfinance.com/ticker/69O" />
About Aelis Farma S.A.S. (69O)

Aelis Farma SA, a clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders. It is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which is in phase I/II clinical trials to treat cognitive deficits observed in Down syndrome, as well as other cognitive impairments. The company was incorporated in 2013 and is headquartered in Bordeaux, France.

Industry

Biotechnology

Sector

Healthcare